IL-33 induces skin inflammation with mast cell and neutrophil activation (Q57231942)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

IL-33 induces skin inflammation with mast cell and neutrophil activation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

0 references

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Neal L. Millar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Iain McInnes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

8

Foo Y Liew

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Chesney Michels

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Jose C Alves-Filho

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Darren L Asquith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

James H Reilly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Gerry J Graham

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Ashley M Miller

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

language of work or name

English

0 references

publication date

24 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

2229-2237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines

4 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Pathogenesis and therapy of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Nuclear interleukin-33 is generally expressed in resting endothelium but rapidly lost upon angiogenic or proinflammatory activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Interleukin-33 is biologically active independently of caspase-1 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

The cytokine interleukin-33 mediates anaphylactic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

The chemokine receptor D6 limits the inflammatory response in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

IL-33 can promote survival, adhesion and cytokine production in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Potent inflammatory properties in human skin of interleukin-1 alpha-like material isolated from normal skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Inflammatory skin disease in transgenic mice that express high levels of interleukin 1 alpha in basal epidermis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

CCR6 is required for IL-23-induced psoriasis-like inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

IL-33 Activates B1 Cells and Exacerbates Contact Sensitivity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

IL-33 induces IL-13-dependent cutaneous fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

GRO-alpha mRNA is selectively overexpressed in psoriatic epidermis and is reduced by cyclosporin A in vivo, but not in cultured keratinocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

Distribution of interleukin 1 receptor antagonist protein (IRAP), interleukin 1 receptor, and interleukin 1 alpha in normal and psoriatic skin. Decreased expression of IRAP in psoriatic lesional epidermis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

Biologically active, alternatively processed interleukin-1 beta in psoriatic scales

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

Expression of IL-18 in psoriasis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041360

7 January 2021

Identifiers

DOI

10.1002/EJI.201041360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21674479%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference